LOCKHEED MARTIN UK AMPTHILL LIMITED

Financial Health Score: A (Excellent)

This grade reflects a robust structural and compliance foundation. While specific trading profitability metrics (like P&L) are not detailed in the current chart, the patient exhibits an exceptionally strong constitution: a massive capital base, perfect regulatory health, and the backing of a global corporate parent. There are no visible symptoms of financial distress.

Key Vital Signs

• Compliance Heartbeat (Regular & Strong): The company’s regulatory heartbeat is steady and healthy. Accounts are filed up to date (with the next due in 2027) and the confirmation statement is current. There are no overdue filings, meaning this patient is not ignoring its regulatory symptoms and is maintaining excellent corporate hygiene.
• Capital Blood Volume (£23.15 Million Share Capital): The share capital acts as the financial blood supply keeping the company’s operations flowing. At over £23 million, the company is exceptionally well-capitalized. This is not an anemic micro-entity; it has the financial reserves required to sustain heavy operational demands.
• Corporate DNA (PSC & Parentage): The company is wholly owned and controlled by Lockheed Martin Uk Ampthill Group. This is the equivalent of having a world-class medical plan—the parent company provides a massive safety net, ensuring the subsidiary can weather industry cycles and absorb operational shocks.
• Longevity & Industry Immunity: Incorporated in 1957 and operating in the manufacture of military fighting vehicles (SIC 30400), this is a mature, resilient patient. The defense sector typically offers long-term contractual stability, acting as a robust immune system against sudden market volatility.
• Filing Transparency (Full Accounts): The company files "Full" accounts rather than abridged or micro-accounts. This indicates a willingness to undergo a thorough, transparent health check rather than hiding underlying issues, which is a strong indicator of corporate confidence.

Diagnosis

Based on the available indicators, Lockheed Martin UK Ampthill Limited is in excellent structural health. The corporate lineage—tracing back through previous names (INSYS Limited, Hunting Engineering Limited)—shows a patient that has evolved and successfully adapted over decades through corporate "transplants" and integrations.

The presence of a highly invested parent company (PSC) and a board of directors comprising both UK and US nationals aligns perfectly with the transatlantic nature of the defense industry. The company shows zero symptoms of distress: no overdue filings, no signs of insolvency, and no history of director disqualifications. The substantial share capital indicates the business is equipped for the high-capital demands of military vehicle manufacturing. While we cannot measure the pulse of daily cash flow or profit margins without the full profit and loss statement, the overall structural diagnosis is one of formidable financial wellness and stability.

Recommendations

Even a healthy patient must maintain good habits to ensure long-term wellness. To maintain this excellent condition, the following preventative measures are recommended:

1. Cardiovascular Exercise (Working Capital Management): With £23.15 million in share capital, ensure that these funds are actively circulated. Capital that sits stagnant can lead to inefficiencies. Regularly monitor working capital to ensure cash is flowing smoothly through the operational arteries, funding R&D and contract fulfillment.
2. Maintain Regulatory Hygiene: Continue the impeccable track record of timely filings. As a subsidiary of a major global defense contractor, public scrutiny is high; maintaining clean, transparent, and on-time "health records" at Companies House is essential for continued trust.
3. Monitor for Geopolitical Blood Pressure: Operating in the defense manufacturing sector means the business environment can change rapidly. Keep a close watch on UK Ministry of Defence budgets and transatlantic trade policies, as these external factors can suddenly elevate operational "blood pressure."